This is a single-center, prospective, pilot clinical trial in which children ages 3-17 years
with eosinophilic esophagitis (EoE) who have a known food that triggers EoE flares receive
oral desensitization with that specific food antigen, followed by reintroduction of that food
into the diet. The purpose of this study is to investigate the safety and feasibility of oral
desensitization in children with EoE so that, if determined to be safe, can be repeated on a
larger scale to determine efficacy.